Brief: Aerovate Therapeutics Inc Files For Mixed Shelf Offering Of Up To $350 Million- SEC Filing
10/06/2024 22:29
Aerovate Therapeutics Inc AVTE.O :
* AEROVATE THERAPEUTICS INC FILES FOR MIXED SHELF OFFERING
OF UP
TO $350 MILLION- SEC FILING
Source text for Eikon: ID:n0001104659-24-070065
Further company coverage: AVTE.O
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million